Αποτελέσματα Αναζήτησης
Sharing Alzheimer’s research data with the world. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
- About
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- News & Publications
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- HELP / FAQ
Documentation. Study Documents page if you’re looking for...
- About
22 Ιουλ 2015 · ! 2 PROTOCOL SYNOPSIS Title Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2) Primary Objective The major goals of ADNI2 are to: 1. Determine the relationships among clinical, imaging, genetic, and biochemical biomarker characteristics of the entire spectrum of Alzheimer’s Disease (AD), as the pathology evolves from normal
Documentation. Study Documents page if you’re looking for study schedules or documents. Background & Rationale page if you’re looking for details about study cohorts. Study Design page if you’re looking for an overview of ADNI and its phases. ADNI3 page if you’re looking for updates on ADNI3.
ADNI will inform the neuroscience of AD, identify diagnostic and prognostic markers, identify outcome measures that can be used in clinical trials, and help develop the most effective clinical trial scenarios.
13 Αυγ 2024 · Since 2004, the Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical Core has overseen the enrollment of > 2400 participants with mild cognitive impairment, mild Alzheimer's disease (AD) dementia, and normal cognition.
The overall goal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer’s disease (AD) clinical trials. ADNI-3, beginning August 1, 2016, is a five year renewal of the current ADNI-2 study.
12 Σεπ 2023 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to improve Alzheimer's disease (AD) clinical trials. Since 2006, ADNI has shared clinical, neuroimaging, and cognitive data, and biofluid s...